FDA Finalizes Guidance for Labeling, Testing of Heparin Products

International Pharmaceutical Regulatory Monitor
A A
The FDA issued guidance on labeling and safety testing for heparin-containing combination products, finalizing the agency’s 2015 draft.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00